Search Results 691-700 of 13411 for Birth Control Palette

1. A Study Evaluating the Long-Term Effectiveness and Safety of Ralinepag in Subjects with PAH Via an Open-Label Extension - Mayo Clinic

   Both male and female subjects agree to use a medically acceptable method of contraception throughout the entire study period from informed consent through the ...

2. A Study to Evaluate 9-ING-41 As a Single Agent or in Combination with Ruxolitinib in Myelofibrosis Patients - Mayo Clinic

   ... contraceptive methods (hormonal or barrier method of birth control, or true abstinence) for the duration of study participation and in the following 100 ...

3. Thumb sucking: Help your child break the habit - Mayo Clinic

   Babies have natural rooting and sucking reflexes, which can cause them to put their thumbs or fingers into their mouths — sometimes even before birth.

4. Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia - Mayo Clinic

   ... contraception (hormonal or barrier method of birth control; abstinence) prior to study entry. Female patients who are of non-reproductive potential (i.e. ...

5. A Study to Evaluate Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin-Angiotensin Aldosterone System Inhibitor (RAASi) Medications for the Treatment of Heart Failure (DIAMOND) - Mayo Clinic

   Females of child-bearing potential must be non-lactating, must have a negative pregnancy test at Screening, and must agree to continue using contraception ...

6. The International Diabetes Closed Loop (iDCL) Trial: Protocol 1 - Mayo Clinic

   The objective of the study is to assess the efficacy and safety of home use of a Control-to-Range (CTR) closed-loop (CL) system. Participation eligibility.

7. Study of Pembrolizumab With Ipilimumab or Placebo in Participants with Untreated Metastatic Non-small Cell Lung Cancer - Mayo Clinic

   ... contraceptive guidance during the treatment ... Note: As of amendment 06, contraception is no longer required for male participants. ... Subjects who use inhaled ...

8. A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4) - Mayo Clinic

   Abstinent or willing to use adequate contraception from Screening through the week 24 visit. Males (as assigned at birth) must fulfill the following criteria:.

9. An Extension Study Of Subjects Who Received An Avalyn Inhaled Antifibrotic Agent (SAIL) - Mayo Clinic

   * Male subjects and female subjects of childbearing potential (FOCBP) agree to use highly effective contraception measures from the time of first dose of ...

10. A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    ... contraception throughout the treatment period and for 6 months after discontinuing study treatment. ... Chronic graft versus host disease (GVHD) or on ...